Skip to main content

William Roper, Viktoria Brough

Human Longevity appointed William Roper its CFO. He had been the firm's interim CFO. The company also promoted Viktoria Brough to vice president of finance, controller. 

Roper spent 17 years as executive vice president of SAIC and was the president and CEO of Verisign. Brough joined Human Longevity in 2014 after spending more than a decade as an auditor at Ernst & Young Assurance practice in San Diego.

The Scan

And For Adolescents

The US Food and Drug Administration has authorized the Pfizer-BioNTech SARS-CoV-2 vaccine for children between the ages of 12 and 15 years old.

Also of Concern to WHO

The Wall Street Journal reports that the World Health Organization has classified the SARS-CoV-2 variant B.1.617 as a "variant of concern."

Test for Them All

The New York Times reports on the development of combined tests for SARS-CoV-2 and other viruses like influenza.

PNAS Papers on Oral Microbiome Evolution, Snake Toxins, Transcription Factor Binding

In PNAS this week: evolution of oral microbiomes among hominids, comparative genomic analysis of snake toxins, and more.